|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2007
Clinical relevance of airway remodelling in airway diseases
1 West Australian Sleep Disorders Research Institute, Queen Elizabeth II Medical Centre, 2 School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. 3 University of Pittsburgh Medical Centre, Pittsburgh, PA, USA.
CORRESPONDENCE: A. L. James, West Australian Sleep Disorders Research Institute, Internal mailbox 201, Queen Elizabeth II Medical Centre, Hospital Avenue, Nedlands, Western Australia 6009, Australia. Fax: 61 893462034. E-mail: ajames{at}it.net.au
Keywords: Asthma, clinical, chronic obstructive pulmonary disease, remodelling
Received: December 13, 2005
Accepted October 2, 2006
Asthma and chronic obstructive pulmonary disease (COPD) are characterised by airflow obstruction, airway remodelling (measurable structural change) and inflammation. The present review will examine the relationship between airway remodelling in these two conditions with respect to symptoms, abnormal lung function, airway hyperresponsiveness and decline in lung function. The potential for remodelling to be a protective response will also be discussed.
Asthma is associated with variable symptoms and changes in lung function and also fixed abnormalities of lung function and an increased rate of decline in lung function with age. There is a relative preservation of the relaxed airway lumen dimensions, prominent thickening of the smooth muscle layer and reduced airway distensibility. The severity of asthma is related to the degree of airway remodelling, which is most marked in cases of fatal asthma.
In COPD, symptoms are persistent and predictable but also progressive and are related to fixed abnormalities of lung function. Remodelling is associated with narrowing of the airway lumen and an increased thickness of the airway wall, although not usually to the extent seen in asthma. COPD is most often due to smoking where there is also remodelling of the parenchyma that may contribute to symptoms.
This article has been cited by other articles:
|
|
 |
|
  J. D. Mark Pediatric Asthma: An Integrative Approach to Care Nutr Clin Pract, October 1, 2009; 24(5): 578 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Grydeland, A. Dirksen, H. O. Coxson, S. G. Pillai, S. Sharma, G. E. Eide, A. Gulsvik, and P. S. Bakke Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking Eur. Respir. J., October 1, 2009; 34(4): 858 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. T. Bates, M. Rincon, and C. G. Irvin Animal models of asthma Am J Physiol Lung Cell Mol Physiol, September 1, 2009; 297(3): L401 - L410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P G Gibson and J L Simpson The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax, August 1, 2009; 64(8): 728 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Williamson, A. L. James, M. J. Phillips, D. D. Sampson, D. R. Hillman, and P. R. Eastwood Quantifying tracheobronchial tree dimensions: methods, limitations and emerging techniques Eur. Respir. J., July 1, 2009; 34(1): 42 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Fanta Asthma N. Engl. J. Med., March 5, 2009; 360(10): 1002 - 1014. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Al-Garawi, R. Fattouh, T. D. Walker, E. B. Jamula, F. Botelho, S. Goncharova, J. Reed, M. R. Stampfli, P. M. O'Byrne, A. J. Coyle, et al. Acute, but Not Resolved, Influenza A Infection Enhances Susceptibility to House Dust Mite-Induced Allergic Disease J. Immunol., March 1, 2009; 182(5): 3095 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Holgate, H. Bisgaard, L. Bjermer, T. Haahtela, J. Haughney, R. Horne, A. McIvor, S. Palkonen, D. B. Price, M. Thomas, et al. The Brussels Declaration: the need for change in asthma management Eur. Respir. J., December 1, 2008; 32(6): 1433 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P-O Bridevaux, M W Gerbase, N M Probst-Hensch, C Schindler, J-M Gaspoz, and T Rochat Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD Thorax, September 1, 2008; 63(9): 768 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Siddiqui, F. Hollins, and C. E. Brightling What can we learn about airway smooth muscle from the company it keeps? Eur. Respir. J., July 1, 2008; 32(1): 9 - 11. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Kim, T. J. Rogers, and G. J. Criner New Concepts in the Pathobiology of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 478 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Laurent, R. J. McAnulty, M. Hill, and R. Chambers Escape from the Matrix: Multiple Mechanisms for Fibroblast Activation in Pulmonary Fibrosis Proceedings of the ATS, April 15, 2008; 5(3): 311 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Chitano, L. Wang, S. N. Mason, R. L. Auten, E. N. Potts, W. M. Foster, A. Sturrock, T. P. Kennedy, J. R. Hoidal, and T. M. Murphy Airway smooth muscle relaxation is impaired in mice lacking the p47phox subunit of NAD(P)H oxidase Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L139 - L148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L-P. Boulet and P. J. Sterk Airway remodelling: the future Eur. Respir. J., November 1, 2007; 30(5): 831 - 834. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |